Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest

  • Authors:
    • Zonghuan Li
    • Yifeng Yu
    • Shaoxing Sun
    • Baiwen Qi
    • Weiyang Wang
    • Aixi Yu
  • View Affiliations

  • Published online on: January 29, 2015     https://doi.org/10.3892/or.2015.3766
  • Pages: 1763-1768
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Niclosamide, used as an antihelminthic, has demonstrated some properties of anticancer effects. However, its role in osteosarcoma remains to be determined. The aim of this study was to determine the effect of niclosamide on human osteosarcoma cell lines. The human MG-63 and U2OS osteosarcoma cell lines were treated with different concentrations of niclosamide. The cell inhibitory rate was calculated by CCK-8 assay. Cell cycle was detected by flow cytometry. Cell apoptosis was determined by Hoechst 33324 staining, flow cytometry and fluorescence microscope, respectively. The expression of bcl-2, bax and pro-caspase-3 were measured by western blotting. Niclosamide exerted an inhibitory effect on the two cell lines in a time- and dose-dependent manner. Niclosamide was found to induce the arrest of S and G2/M phase in U2OS cells and G2/M in MG-63 cells. Moreover, niclosamide induced apoptosis in MG-63 and U2OS cells. The bax/bcl-2 ratio increased while the expression of pro‑caspase-3 decreased significantly in the two cell lines. The results indicated that niclosamide inhibits proliferation, and induces apoptosis and cell cycle arrest in human osteosarcoma cell lines.

References

1 

Biermann JS, Adkins DR, Agulnik M, et al: Bone cancer. J Natl Compr Canc Netw. 11:688–723. 2013.PubMed/NCBI

2 

Hogendoorn PC; ESMO/EUROBONET Working Group. Athanasou N, Bielack S, et al: Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21(Suppl 5): v204–v213. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Londono-Joshi AI, Arend RC, Aristizabal L, et al: Effect of niclosamide on basal-like breast cancers. Mol Cancer Ther. 13:800–811. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Ye T, Xiong Y, Yan Y, et al: The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model. PLoS One. 9:e858872014. View Article : Google Scholar : PubMed/NCBI

5 

Sack U, Walther W, Scudiero D, et al: Novel effect of anti-helminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst. 103:1018–1036. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Wieland A, Trageser D, Gogolok S, et al: Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res. 19:4124–4136. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Jin Y, Lu Z, Ding K, et al: Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res. 70:2516–2527. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Liu C, Lou W, Zhu Y, et al: Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. Clin Cancer Res. 20:3198–210. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Li R, Hu Z, Sun SY, et al: Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer. Mol Cancer Ther. 12:2200–2212. 2013. View Article : Google Scholar : PubMed/NCBI

10 

You S, Li R, Park D, et al: Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. Mol Cancer Ther. 13:606–616. 2014. View Article : Google Scholar :

11 

Li R, You S, Hu Z, et al: Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer. PLoS One. 8:e746702013. View Article : Google Scholar : PubMed/NCBI

12 

Yo YT, Lin YW, Wang YC, et al: Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 11:1703–1712. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Arend RC, Londoño-Joshi AI, Samant RS, et al: Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer. Gynecol Oncol. 34:112–120. 2014. View Article : Google Scholar

14 

Chen W, Chen M and Barak LS: Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach. Am J Physiol Gastrointest Liver Physiol. 299:G293–G300. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Li Y, Li PK, Roberts MJ, et al: Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett. 349:8–14. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Pan JX, Ding K and Wang CY: Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells. Chin J Cancer. 31:178–184. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Wang AM, Ku HH, Liang YC, et al: The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem. 106:682–692. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Ren X, Duan L, He Q, et al: Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Med Chem Lett. 1:454–459. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Reed JC: Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13:1378–1386. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609–619. 1993. View Article : Google Scholar : PubMed/NCBI

21 

Korsmeyer SJ, Shutter JR, Veis DJ, et al: Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332. 1993.PubMed/NCBI

22 

Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI

23 

Cohen GM: Caspases: the executioners of apoptosis. Biochem J. 326:1–16. 1997.PubMed/NCBI

24 

Lu W, Lin C, Roberts MJ, et al: Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway. PLoS One. 6:e292902011. View Article : Google Scholar

25 

Tomizawa M, Shinozaki F, Motoyoshi Y, et al: Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway. Onco Targets Ther. 6:1685–1693. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Fonseca BD, Diering GH, Bidinosti MA, et al: Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling. J Biol Chem. 287:17530–17545. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Balgi AD, Fonseca BD, Donohue E, et al: Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One. 4:e71242009. View Article : Google Scholar : PubMed/NCBI

28 

Lee SL, Son AR, Ahn J, et al: Niclosamide enhances ROS-mediated cell death through c-Jun activation. Biomed Pharmacother. 68:619–624. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2015
Volume 33 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, Z., Yu, Y., Sun, S., Qi, B., Wang, W., & Yu, A. (2015). Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest. Oncology Reports, 33, 1763-1768. https://doi.org/10.3892/or.2015.3766
MLA
Li, Z., Yu, Y., Sun, S., Qi, B., Wang, W., Yu, A."Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest". Oncology Reports 33.4 (2015): 1763-1768.
Chicago
Li, Z., Yu, Y., Sun, S., Qi, B., Wang, W., Yu, A."Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest". Oncology Reports 33, no. 4 (2015): 1763-1768. https://doi.org/10.3892/or.2015.3766